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Edited by Miguel De la RosaAbstract The soluble fumarate reductase (FR) from Shewa-
nella frigidimarina can catalyse the reduction of 2-methylfuma-
rate with a kcat of 9.0 s
1 and a KM of 32 lM. This produces
the chiral molecule 2-methylsuccinate. Here, we present the
structure of FR to a resolution of 1.5 A˚ with 2-methylfumarate
bound at the active site. The mode of binding of 2-methylfuma-
rate allows us to predict the stereochemistry of the product as
(S)-2-methylsuccinate. To test this prediction we have analysed
the product stereochemistry by circular dichroism spectroscopy
and conﬁrmed the production of (S)-2-methylsuccinate.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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During anaerobic respiration many bacteria can utilise
fumarate as a terminal electron acceptor. In most cases bacte-
rial fumarate reductases (FRs) are cytoplasmic, membrane-
associated complexes related to the succinate dehydrogenases,
and contain iron–sulfur centres and ﬂavin adenine dinucleotide
(FAD) as cofactors [1,2]. In contrast, Shewanella species pro-
duce a soluble periplasmic FR which contains four c-type
heme groups and one FAD, and as such is designated a ﬂavo-
cytochrome c3. A number of crystal structures of the FR from
Shewanella frigidimarina have been reported [3–5]. The highest
resolution structure is to 1.8 A˚ (PDB ID 1QJD), and based
upon this structure a mechanism for fumarate reduction has
been proposed [3]. This mechanism involves the use of
Arg402 as the active-site acid according to the scheme shown
in Fig. 1, and is corroborated by further studies on site-direc-
ted mutant forms of the enzyme [6].Abbreviations: FR, fumarate reductase; FAD, ﬂavin adenine dinucle-
otide; CD, circular dichroism spectroscopy
q The atomic coordinates have been deposited in the protein data
bank, entry 1Y0P.
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doi:10.1016/j.febslet.2006.02.016Fumarate reduction by FR is known to be competitively
inhibited by 2-methylfumarate (also known as mesaconate)
with a Ki of 1.0 lM. However, we show in the present paper
that 2-methylfumarate is actually a substrate for FR. Unlike
fumarate reduction by FR, which leads to the formation of
the achiral product succinate, the reduction of 2-methylfuma-
rate should result in the production of the chiral molecule
2-methylsuccinate. Depending upon the mode of binding of
2-methylfumarate at the active site of the enzyme, the product
will be either (S)- or (R)-2-methylsuccinate. In order to investi-
gate this we have obtained the crystal structure of FR with 2-
methylsuccinate bound and have examined the FR-catalysed
reduction of 2-methylfumarate by steady-state kinetics. In
addition, we have carried out an electrocatalytic bulk reduction
of 2-methylfumarate by FR, and identiﬁed the stereochemistry
of the resultant 2-methylsuccinate by circular dichroism spec-
troscopy (CD). The results conﬁrm our predicted trajectories
for hydride and proton transfer in the catalytic mechanism.2. Materials and methods
2.1. Protein expression and puriﬁcation and determination of FAD
content
Wild type FR was expressed and puriﬁed as previously reported [7].
The FAD content of the FR preparations was determined by the meth-
od of Macheroux [8]. All steady-state rate constants were corrected for
the percentage of FAD present.2.2. Crystallisation and reﬁnement
Crystallisation of wild-type FR was carried out by hanging-drop
vapour diﬀusion at 4 C in Linbro plates. Crystals were obtained with
well solutions comprising 100 mM Tris–HCl buﬀer (pH 7.8–8.5)
(measured at 25 C), 80 mM NaCl, 16–19% PEG 8000, and 1 mM
2-methylfumarate. Hanging drops (4 ll volume) were prepared by
adding 2 ll of 6 mg/ml protein (in 10 mM Tris–HCl pH 8.5) to 2 ll
of well solution. After approximately seven days needles of up to
1 mm · 0.2 mm · 0.2 mm and plates of up to 0.5 mm · 0.5 mm ·
0.2 mm were formed. Crystals were immersed in a solution of
100 mM sodium acetate buﬀer (pH 6.5), 20% PEG 8000, 1 mM 2-
methylfumarate, and 80 mM NaCl, containing 23% glycerol as a
cryoprotectant, prior to being mounted in nylon loops and ﬂash
cooled in liquid nitrogen. A data set was collected to 1.5 A˚ at station
14.1 (k = 0.975 A˚) at SRS Daresbury using an ADSC Quantum 4
CCD detector. Crystals belonged to space group P21 with cell dimen-
sions a = 45.449 A˚, b = 91.687 A˚, c = 78.287 A˚, and b = 91.13. Data
processing was carried out using the HKL package [9]. The wild-type
FR structure (PDB ID 1QJD), stripped of water, was used as the ini-
tial model. Electron-density ﬁtting was carried out using the program
Turbofrodo [10] and structure reﬁnement by using Refmac [11].blished by Elsevier B.V. All rights reserved.
Fig. 1. The reaction mechanism for fumarate reduction in FR (this is
an abbreviated version of the mechanism proposed by Taylor et al. [3]).
The substrate is polarised by interactions with charged residues
facilitating hydride transfer from N5 of the reduced FAD to C2 of the
substrate. Arg402 is ideally positioned to donate a proton to C3 of the
substrate, resulting in the formation of succinate. Arg402 is immedi-
ately reprotonated via a proton pathway involving Arg381 and
Glu378.
Table 1
Data collection and reﬁnement statistics
Resolution (A˚) 24.0–1.5
Total number of reﬂections 678137
Number of unique reﬂections 99564 (9590)a
Completeness (%) 97.2 (94.0)a
I/[r(I)] 21.0 (3.1)a
Rmerge (%)
b 4.8 (37.3)a
Rcryst (%)
c 15.08
Rfree (%)
c 18.35
RMSD from ideal values
Bond lengths (A˚) 0.014
Bond angles () 1.5
Ramachandran analysis
Most favoured (%) 88.1
Additionally allowed (%) 11.7
aValues in parentheses indicate statistics for the highest resolution shell
(1.55–1.50 A˚).
bRmerge =
P
h
P
i|I(h)  II(h)|/
P
h
P
iII(h), where II(h) and I(h) are the ith
and mean measurement of reﬂection h, respectively.
cRcryst =
P
h|Fo  Fc|/
P
hFo, where Fo and Fc are the observed and
calculated structure factor amplitudes of reﬂection h, respectively. Rfree
is the test reﬂection data set, 5% selected randomly for cross validation
during crystallographic reﬁnement.
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The steady-state kinetics of 2-methylfumarate reduction were fol-
lowed at 25 C as described by Turner et al. [12]. The 2-methylfuma-
rate-dependent reoxidation of reduced methyl viologen was
monitored at 600 nm using a Shimadzu UV-PC 1501 spectrophotom-
eter. To ensure anaerobicity, the spectrophotometer was housed in a
Belle Technology glovebox under a nitrogen atmosphere with the O2
level below 5 ppm. Assay buﬀers contained 0.45 M NaCl and
0.2 mM methyl viologen and were adjusted to the appropriate pH val-
ues using 0.05 M HCl or NaOH as follows: Tris–HCl at pH 7.0–9.0,
MES/NaOH at pH 5.4–6.8, and CHES/NaOH at pH 8.6–10.0. The
viologen was reduced by addition of sodium dithionite until a reading
of 1 absorbance unit was obtained (corresponding to 80 lM re-
duced methyl viologen). The concentration of reduced methyl viologen
could be varied from 20 to 100 lM with no eﬀect on the rate of reac-
tion. A known concentration of the enzyme was added and the reac-
tion initiated by addition of 2-methylfumarate (0–1 mM).
Kinetic parameters KM and kcat were determined from steady-state
results using non-linear-regression analysis (Microcal Origin software).
2.4. Electrocatalytic reduction of 2-methylfumarate
In order to carry out subsequent CD analysis, millimolar concentra-
tions of product were required. Therefore, bulk reduction of 2-methyl-
fumarate was carried out under anaerobic conditions at 25 C in
0.05 M MOPS/NaOH buﬀer, pH 7.0, containing 0.5 M KF, 50 lM
methyl viologen, and 5 mM 2-methylfumarate. The concentration of
FR was approximately 1 lM. The electrodes used were platinum with
a Ag/AgCl reference electrode. The potential was held at 0.6 V until
reaction completion was indicated by cessation of current ﬂow. After
completion protein was separated from product by centrifugation
through a 10 kDa membrane (Millipore).
2.5. Circular dichroism spectroscopy
CD spectroscopy was carried out using a Jasco J-810 spectropolar-
imeter and a 1 cm pathlength quartz cell. CD spectra of the product
was compared with the spectra of enantiomerically pure solutions of
500 lM (R) and (S)-methylsuccinate (Sigma).3. Results and discussion
3.1. Crystal structure of FR with 2-methylfumarate bound
A data set to 1.5 A˚ resolution was used to reﬁne the struc-
ture to a ﬁnal R-factor of 15.08% (Rfree = 18.35%), data collec-
tion and reﬁnement statistics are summarised in Table 1. Theﬁnal model consists of one protein molecule comprising resi-
dues 1–568, four hemes, one FAD, one sodium ion, one 2-
methylfumarate molecule, and 1249 water molecules. The
atomic coordinates have been deposited in the protein data
bank, accession code 1Y0P.
The binding of 2-methylfumarate is illustrated by the Fo–
Fc omit map shown in Fig. 2A. As found for other FR
structures, residues 569–571 at the C-terminus of the enzyme
could not be located in the electron density maps. The
RMSD ﬁt of all backbone atoms between this model and
the earlier wild-type enzyme structure (PDB ID 1QJD) [3]
is 0.2 A˚, indicating no major diﬀerences between the two
protein structures. 2-Methylfumarate is found at the active
site of the enzyme in the same twisted conformation ob-
served for the malate-like molecule (henceforth referred to
as malate for the sake of simplicity) in the original crystal
structure (PDB ID 1QJD) [3] and for fumarate in structures
of mutant forms of the enzyme (e.g., PDB ID 1JRX) [6]. The
binding of 2-methylfumarate and malate (from the structure
of Taylor et al. [3]) to FR is shown in Fig. 2B. The ligands
are completely superposable with the exception of the C2-
substituents. Thus, bound 2-methylfumarate maintains the
same interactions with the protein as displayed by malate.
These include an electrostatic interaction between the C1-car-
boxylate group and the positively-charged sidechains of
Arg544 and His504 which serve to polarise and activate
the double bond for hydride attack by FAD. The C4-carbox-
ylate end of 2-methylfumarate is hydrogen bonded to several
residues including His365 and Thr377. The interactions of 2-
methylfumarate at the active site of FR are shown in
Fig. 2C. The mechanism of 2-methylfumarate reduction is
assumed to be the same as that shown for fumarate in
Fig. 1, and is proposed to involve proton delivery via a path-
way comprised of Arg381, Glu378, and Arg402. In the 2-
methylfumarate-bound protein all proton transfer distances
are identical to those observed in the malate-bound struc-
ture, as is the hydride transfer distance from FAD to sub-
strate.
The physiological reaction of FR results in the formation
of the achiral product succinate. In contrast to this, reduction
Fig. 3. Schematic representation of 2-methylsuccinate generation by
FR. Panel (A) illustrates the situation as observed in the crystal
structure resulting in (S)-methylsuccinate. Panel (B) shows the
production of (R)-methylsuccinate if 2-methylfumarate were bound
in the same way as malate in the original crystal structure.
Fig. 2. (A) Stereoview of the region surrounding the FAD and bound
2-methylfumarate in FR. The electron density shown is a simulated
annealing omit map calculated using Fourier coeﬃcients Fo–Fc, where
Fo and Fc are the observed and calculated structure factors, respec-
tively, the latter based on the ﬁnal model. The contour level is 3r,
where r is the RMS electron density. (B) The left panel shows 2-
methylfumarate at the active site of the enzyme while the right panel
shows malate in the active site (from PDB IDB 1QJD [3]). (C)
Stereoview of the active site of FR with 2-methylfumarate bound.
Residues important for substrate binding and catalysis are shown. The
ﬁgure was made using BOBSCRIPT [13] and RASTER 3D [14].
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tion of either (R)- or (S)-methylsuccinate, depending upon
the mode of binding of 2-methylfumarate during catalysis.
This is shown schematically in Fig. 3. Speciﬁcally, when 2-
methylfumarate is bound as observed in the structure re-
ported here then the product will be (S)-methylsuccinate
(see Fig. 3A). If 2-methylfumarate had bound in a mode
analogous to that seen for malate (see Fig. 2B), i.e., with
the methyl group in the same position as the malate 2-hydro-
xyl group, then the product would be (R)-methylsuccinate
(see Fig. 3B). In this way, the crystal structure of the en-
zyme/substrate complex enables the prediction of the hydride
and proton trajectories and hence the stereochemistry of the
chiral product.3.2. Steady-state kinetics
The ability of FR to catalyse 2-methylfumarate reduction
was assayed at a range of pH values between 6.0 and 10.0.
At pH 7.2, the FR-catalysed reduction of 2-methylfumarate
gave a kcat value of 9.0 ± 0.4 s
1 and a KM of 32 ± 8 lM. At
the same pH, fumarate gives rise to a kcat value of
509 ± 15 s1 and a KM of 43 ± 10 lM. Thus although both
substrates exhibit similar KM values, the kcat value seen for
fumarate is some 50-fold larger than that seen with 2-meth-
ylfumarate. The structural data would suggest that there is
no problem with the binding and orientation of 2-methyl-
fumarate and so it is unlikely that the fall in kcat is due
to steric reasons. The more likely reason is the positive
inductive aﬀect of the methyl group. It has been proposed
that the transition state for the reaction involves the build
up of negative charge on the substrate [3]. This suggestion
is consistent with our results, since the methyl group would
disfavour the build up of negative charge, raising the energy
of the transition state and consequently lowering the kcat
value.3.3. Characterisation of electrocatalytically produced
2-methylsuccinate using CD spectroscopy
The ability to use an electrode to drive fumarate reduction
by FR has been previously demonstrated [12], and electro-
chemistry has become a valuable technique in the study of
the enzyme. Thus, in order to produce enough product for
analysis by CD spectroscopy, we carried out an electrocata-
lytically driven bulk enzymatic reduction of 2-methylfuma-
rate. The CD spectrum of the 2-methylsuccinate produced
was compared with those of pure (R)- and (S)-methylsucci-
nate, and these are shown overlaid in Fig. 4. It can be seen
from this ﬁgure that the product spectrum is identical to
that of pure (S)-methylsuccinate, indicating that reduction
of 2-methylfumarate by FR results in the production of
(S)-methylsuccinate.3.4. Conclusions
We have shown that FR can catalyse the reduction of 2-
methylfumarate, a molecule previously thought to be only
Fig. 4. CD spectra of product 2-methylsuccinate (black), (R)-2-
methylsuccinate (red), and (S)-2-methylsuccinate (blue). All the
compounds were at the same concentration of 5 mM. Spectra represent
an average of 5 scans at 10 nm per minute.
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methylfumarate complex has allowed us to visualise the
binding of this substrate at the active site of the enzyme.
This structure, in combination with the previously proposed
mechanism for catalysis by FR [3], has enabled us to predict
the trajectories for hydride and proton transfer to 2-methyl-
fumarate. This suggested that the resulting product should
be (S)-methylsuccinate and this has been conﬁrmed by CD
spectroscopy adding strong support to the validity of the
proposed mechanism.
We note that the ability of FR to produce chiral com-
pounds from achiral precursors at millimolar concentrations
may have future applications. The mild reaction conditions
and use of an electrode as a reductant could provide an eﬃ-
cient and inexpensive route to further compounds. Clearly
the scope of the method is determined by the ability of the
enzyme to accommodate and catalyse the reduction of fur-
ther compounds. Current eﬀorts are centred upon determin-
ing which precursor compounds are viable substrates for
wild-type FR, and a programme of site-directed mutagenesis
is under way in an eﬀort to alter the substrate speciﬁcity of
the enzyme and therefore maximise the applicability of the
method.Acknowledgements: This work was supported by the UK Biotechnol-
ogy and Biological Sciences Research Council (BBSRC) and by the
Wellcome Trust funded Edinburgh Protein Interaction Centre (EPIC).
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